- Home
- LGVN vs BHIL Comparison
LGVN vs BHIL Comparison
Compare LGVN & BHIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- BHIL
- Stock Information
- Founded
- LGVN 2014
- BHIL 2012
- Country
- LGVN United States
- BHIL United States
- Employees
- LGVN N/A
- BHIL N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- BHIL Packaged Foods
- Sector
- LGVN Health Care
- BHIL Consumer Staples
- Exchange
- LGVN Nasdaq
- BHIL Nasdaq
- Market Cap
- LGVN 26.0M
- BHIL 27.1M
- IPO Year
- LGVN 2021
- BHIL N/A
- Fundamental
- Price
- LGVN $1.70
- BHIL $1.89
- Analyst Decision
- LGVN Strong Buy
- BHIL
- Analyst Count
- LGVN 3
- BHIL 0
- Target Price
- LGVN $8.67
- BHIL N/A
- AVG Volume (30 Days)
- LGVN 314.6K
- BHIL 33.0K
- Earning Date
- LGVN 02-25-2025
- BHIL 03-13-2025
- Dividend Yield
- LGVN N/A
- BHIL N/A
- EPS Growth
- LGVN N/A
- BHIL N/A
- EPS
- LGVN N/A
- BHIL N/A
- Revenue
- LGVN $1,852,000.00
- BHIL $466,725,000.00
- Revenue This Year
- LGVN $208.32
- BHIL N/A
- Revenue Next Year
- LGVN $43.96
- BHIL N/A
- P/E Ratio
- LGVN N/A
- BHIL N/A
- Revenue Growth
- LGVN 141.46
- BHIL 139.60
- 52 Week Low
- LGVN $0.77
- BHIL $1.67
- 52 Week High
- LGVN $10.30
- BHIL $11.03
- Technical
- Relative Strength Index (RSI)
- LGVN 41.48
- BHIL 35.58
- Support Level
- LGVN $1.72
- BHIL $1.67
- Resistance Level
- LGVN $1.89
- BHIL $2.50
- Average True Range (ATR)
- LGVN 0.14
- BHIL 0.25
- MACD
- LGVN -0.00
- BHIL 0.06
- Stochastic Oscillator
- LGVN 8.47
- BHIL 25.97
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About BHIL Benson Hill Inc.
Benson Hill Inc is an ag-tech company specializing in soy protein innovation. The company has one business segment Ingredient. The company focuses on seed innovation through proprietary germplasm and the CropOS platform. This platform integrates protein, genomic, and strategic data for predictive breeding using AI and ML. They operate a Crop Accelerator for rapid prototyping. Benson Hill is developing a seed portfolio for protein ingredients, aquaculture, specialty animal feed, and vegetable oils. The company's revenue can be disaggregated into product categories: Proprietary and Non-Proprietary. Proprietary revenue is defined as any sale of a proprietary bean. Non-Proprietary revenue is all other revenue from non-Proprietary sources.